White House strikes deals for lower prices on obesity drugs
Novo Nordisk agreed to lower the price for its obesity drug Wegovy in a deal with the Trump administration announced Thursday. Dhiraj Singh/Bloomberg via Getty Images hide caption toggle caption Dhiraj Singh/Bloomberg via Getty Images People who rely on Medicare for their health insurance will soon be able to get blockbuster obesity and Type 2






